▾

1st High-tech Enterprise focusing on
Interventional Intravascular Imaging
in China

A Medical device company incubated and supported by
Xi’an Institute of Optics and Precision Mechanics, Chinese Academy of Sciences

About Vivolight

Founded in 2012, Vivolight is a medical device company incubated and supported by Xi'an Institute of Optics and Precision Mechanics of Chinese Academy of Sciences. We are headquartered in Shenzhen and have established an R&D center in Xi’an. Rooted in the field of medical laser technology, we are committed to the independent development, global innovation and independent manufacturing of medical devices used for minimally invasive interventional diagnosis and treatment with the technology of laser by leveraging the world-leading photoelectric technology and combining medicine and engineering.

In April 2020, our self-developed optical coherence tomography (OCT) system obtained the approval of NMPA and achieved commercialization. In December 2021, our innovative Multimodality OCT System was approved by NMPA. It is the first Multimodality OCT System in the field of coronary artery OCT that has been approved for clinical application. In the field of interventional laser therapy, we have multiple products that have entered the phase of pre-clinical study.

Global leading technique of

Electro-Optics

Close cooperation between

Clinical + Industry

Focus on

Innovative Interventional Laser Medical Device

  • 1st globally

    3 in1 intravascular imaging system

  • Unique innovation

    VFR+IPA techniques

  • 62 Approved patents

    54 Patents in process

  • 10 Years

    Technique Heritage

  • ~40%

    R&D team

Milestones of Vivolight

2023

The Multimodality OCT System won the 2022 Top Ten Optical Industry Technologies in China

Vivolight Medical reached a strategic partnership with Siemens Healthineers

2022

The portable OCT imaging system Cornaris® Mobile received approval and certification

The second-generation OCT catheter LumenCross F2 received approval and certification from the NMPA

2021

The innovative multimodality OCT system Cornaris® P80 has been approved and certified

Cornaris® P80 won the 2021 Red Dot Award in Germany

2020

The first-generation coronary OCT system Cornaris® P60 has been approved for the NMPA Class III medical device product registration certificate

Vivolight Medical donated over a hundred devices to support the fight against the COVID-19 pandemic

2018

The cardiovascular OCT system has completed the clinical trial

Clinical trial for OCT completed

2017

The infrared projection vein finder product has received FDA approval

Projection vein finder got FDA approval

2016

The cardiovascular OCT system has undergone animal cardiovascular stent implantation experiments for the first time

Animal study for OCT system

2014

The infrared projection vein finder device assisted the Chinese medical team in traveling to Liberia, Africa to combat the Ebola epidemic

Obtained TÜV ISO 13485 Quality system certificate

2013

Projection vein finder developed and launched in overseas market

The first generation of infrared projection vein finder device was successfully developed and officially entered the market

2012

Establishment

Mission & Vision

Mission

To lead revolution of minimally invasive therapies with photonics technology

Vision

To become a world-leading manufacturer of minimally invasive interventional laser diagnosis and treatment device

Honors and Awards

  • 2021
  • 2020
  • 2018
  • 2017
  • 2015
  • 2014

Media Report

ico_arrow_round_l
ico_arrow_round_r
Copyright 2023 Shenzhen Vivolight Medical Device & Technology Co., Ltd. All Rights Reserved|粤ICP备12074423号